SC-VC-PAB-N-Me-L-Ala-Maytansinol

Modify Date: 2025-08-22 12:29:43

SC-VC-PAB-N-Me-L-Ala-Maytansinol Structure
SC-VC-PAB-N-Me-L-Ala-Maytansinol structure
Common Name SC-VC-PAB-N-Me-L-Ala-Maytansinol
CAS Number 2226467-76-9 Molecular Weight 1365.91
Density N/A Boiling Point N/A
Molecular Formula C65H89ClN10O20 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SC-VC-PAB-N-Me-L-Ala-Maytansinol


SC-VC-PAB-N-Me-L-Ala-Maytansinol (compound B1) can be used to synthesis MCC-Maytansinoid A. SC-VC-PAB-N-Me-L-Ala-Maytansinol can be used as a control compound for the cancer research[1].

 Names

Name SC-VC-PAB-N-Me-L-Ala-Maytansinol

 SC-VC-PAB-N-Me-L-Ala-Maytansinol Biological Activity

Description SC-VC-PAB-N-Me-L-Ala-Maytansinol (compound B1) can be used to synthesis MCC-Maytansinoid A. SC-VC-PAB-N-Me-L-Ala-Maytansinol can be used as a control compound for the cancer research[1].
Related Catalog
References

[1]. ANDREEV JULIAN, et al. BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND METHODS OF USE THEREOF. WO2021174113. 2021.

 Chemical & Physical Properties

Molecular Formula C65H89ClN10O20
Molecular Weight 1365.91
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
Fmoc-N-Me-L-Ala-maytansinol
1452404-52-2
N-Me-L-Ala-maytansinol
77668-69-0
Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine
2249935-19-9
SC-VC-PAB-DM1
2259318-47-1
SC-VC-PAB-MMAE
2259318-46-0
(3S,6S,9S,12R,15S,18S)-9-(4-Amino-butyl)-3-benzyl-6-ethyl-15-(4-hydroxy-benzyl)-12-(1H-indol-3-ylmethyl)-1,18-dimethyl-1,4,7,10,13,16-hexaaza-cyclooctadecane-2,5,8,11,14,17-hexaone
121715-55-7
Fmoc-N-Me-3-(4-py)-L-Ala
2381854-90-4
Fmoc-N-Me-Ala(3-pyridyl)-OH
1979173-93-7
L-Alanine, N-methyl-, 1,1-dimethylethyl ester (9CI)
114525-98-3
N-(2-(((3-(5-methylisoxazol-3-yl)-1,2,4-oxadiazol-5-yl)methyl)amino)-2-oxoethyl)benzamide
2034287-89-1
2-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)oxy)-N-((3-(5-methylisoxazol-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide
2034320-95-9
6-oxo-N-((6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-1,4,5,6-tetrahydropyridazine-3-carboxamide
1904178-39-7
4-methyl-2-(1H-pyrrol-1-yl)-N-((6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)thiazole-5-carboxamide
2034533-80-5
5-(furan-2-yl)-N-((6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)isoxazole-3-carboxamide
1903425-35-3
4-((1H-imidazol-1-yl)methyl)-N-((6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)benzamide
1903604-74-9
(E)-3-(2-chlorophenyl)-N-((6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)acrylamide
1904626-03-4
Methyl 4-(((6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)carbamoyl)benzoate
2034367-95-6
2-(4-oxoquinazolin-3(4H)-yl)-N-((6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)acetamide
1904020-13-8
N-((6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide
1903278-06-7